Rating: HOLD
HOLD (5-tier) · cyclical compounder · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $121 |
| Triangulated Fair Value | $109 (-10% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $114 (-5% vs spot · 12m PWEV) |
| Forward P/E | 21.9x |
| Market Cap | $29B |
| 52-Week Range | $105–$153 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | cyclical compounder · medium |
| Triangulated fair value | $109 (-10% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $114 (-5% vs spot · 12m PWEV) |
| Next catalyst | 2026-02-03 — Q4/FY2025 results, FY2026 organic guide and Evoqua-synergy update |
| Primary thesis-break | Organic revenue growth (y/y) < 0.01 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -5% vs spot
- Monte Carlo median implies -15% vs spot
- DCF fair value implies -19% vs spot
- Bear case (Structural — Portfolio / End-Market Disruption) downside is -55% vs spot
- Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At roughly 118 the shares trade near 21x forward earnings, a mid-cycle multiple that assumes short-cycle industrial demand normalises and the 17.5% operating margin holds. The market is paying for steady organic growth and disciplined capital allocation, not for a re-rate. Our engine reaches a probability-weighted target of about 116, essentially the spot price, because the P/E multiple and gross margin together account for the bulk of the variance and both cut in either direction. The base case earns roughly 5.60 in EPS at a 21x multiple; the structural and recession legs, which carry a combined 37% weight, drag the blend down to the current price. That balance is why the rating is HOLD rather than a directional call: triangulated fair value sits below spot on the DCF anchor near 99 yet above it on the peer lines, and neither dominates. The single most damaging risk is a short-cycle destock: two soft order prints would collapse the mid-cycle premium and route the valuation toward the recession path near the low-80s. Net cash is negative, so the balance sheet offers little cushion in that state.
The dashboard below is the whole argument on one page: spot ($121) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear leg is the Industrial-PMI Recession, at 17% on its own and part of a 37% recessionary bucket. The mechanism is concrete. Short-cycle industrial demand turns with PMI; when customers destock, Xylem's volumes fall faster than pricing can offset, and the largely fixed cost base delivers negative operating leverage. Margin gives back toward 15.5% while organic growth turns negative for a year or more. The multiple compresses in sympathy from 21x to a cyclical 18x, and the two effects multiply rather than add. With net debt of 1.25 billion and a modest dividend commitment, there is limited buffer to defend the multiple through the trough. Book-to-bill below one for two quarters would confirm it is under way.
Key Debate
P/E Multiple explains 52% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.57 vs analyst floor +0.01 → delta +0.56 (n=20 mgmt / 14 Q&A; 82th pctile across the S&P book, z +1.0).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.57 | +0.01 | +0.56 |
| 2025Q4 | +0.27 | +0.11 | +0.16 |
| 2025Q3 | +0.48 | +0.05 | +0.42 |
| 2025Q2 | +0.57 | +0.15 | +0.42 |
News (last 365d, 1000 articles): avg ticker sentiment +0.22 (bullish 34% / bearish 5%)
Scenario Analysis
The tree runs from a structural 'Structural — Portfolio / End-Market Disruption' downside ($54) to a 'Bull — Re-Rate' bull case ($196); the probability-weighted blend (PWEV $114) is -5% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Portfolio / End-Market Disruption | 20% | $54 | -55% |
| Industrial-PMI Recession | 17% | $83 | -31% |
| Base — Organic Growth + Margin | 35% | $118 | -2% |
| Growth — Productivity / Reshoring / Automation | 20% | $161 | +33% |
| Bull — Re-Rate | 8% | $196 | +62% |
| Probability-Weighted (PWEV) | — | $114 | -5% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Portfolio / End-Market Disruption (20%, $54). Structural impairment — portfolio / end-market disruption: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 51.0; probability: 0.2.
- Industrial-PMI Recession (17%, $83). Cyclical downturn — short-cycle industrial demand (PMI) + pricing + portfolio/automation mix weakens for 1–2 years before normalising. Drivers — implied_target: 86.62; probability: 0.17.
- Base — Organic Growth + Margin (35%, $118). Mid-cycle — normalised short-cycle industrial demand (PMI) + pricing + portfolio/automation mix; disciplined capital allocation; steady returns. Drivers — implied_target: 120.3; probability: 0.35.
- Growth — Productivity / Reshoring / Automation (20%, $161). Upside — productivity + reshoring + automation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 162.4; probability: 0.2.
- Bull — Re-Rate (8%, $196). Upside tail — sustained tight conditions or a structural re-rate on productivity + reshoring + automation. Drivers — implied_target: 205.11; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $103 | -15% |
| Peer P/E re-rate | multiple | $145 | +20% |
| Peer EV/Revenue re-rate | multiple | $182 | +51% |
| Scenario PWEV | multiple | $114 | -5% |
| DCF (5-year + terminal) | cash flow + terminal × | $98 | -19% |
| Triangulated (weighted) | — | $109 | -10% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $103 and 37% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (52% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 18x terminal FCF multiple → $98. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 26.325x) implies $145. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 74% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Diversified Industrial Machinery | $9.1B | 100% | 5% | 18% | $1.6B | 21x | 3% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | short-cycle industrial demand (PMI) + pricing + portfolio/automation mix |
| net_debt_or_cash_b | -1.25 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.0145 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | portfolio / end-market disruption |
| upside | productivity + reshoring + automation |
Industry Context — Ind Machinery
This name sits in the Ind Machinery as a diversified_industrials. short-cycle industrial demand (PMI) + pricing + portfolio/automation mix Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: CAT (heavy_machinery) · DE (heavy_machinery) · HON (diversified_industrials) · PH (diversified_industrials) · CMI (heavy_machinery) · MMM (diversified_industrials) · ITW (diversified_industrials) · GWW (diversified_industrials) · PCAR (heavy_machinery) · WAB (heavy_machinery) · IR (diversified_industrials) · DOV (diversified_industrials) · OTIS (diversified_industrials) · HUBB (diversified_industrials) · XYL (diversified_industrials) · SNA (diversified_industrials) · FTV (diversified_industrials) · NDSN (diversified_industrials) · IEX (diversified_industrials) · SWK (diversified_industrials) · PNR (diversified_industrials)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Industrial-PMI Recession / Inventory Reset | 37% | 37% | |
| Mid-Cycle — Volumes + Pricing | 35% | 35% | |
| Upcycle — Capex / Reshoring / Infra | 28% | 28% |
Mapping note: name-level 'Structural — Portfolio / End-Market Disruption' (20%) + 'Industrial-PMI Recession' (17%) map to cluster Industrial-PMI Recession / Inventory Reset (37%); name-level 'Growth — Productivity / Reshoring / Automation' (20%) + 'Bull — Re-Rate' (8%) map to cluster Upcycle — Capex / Reshoring / Infra (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Industrial-PMI Recession / Inventory Reset () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The ind_machinery cycle is the shared macro driver. Driver — industrial capex + PMI + construction/ag/heavy-truck demand + reshoring Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $10B | $2B | $0B | $0B | $1B | $1B |
| FY+2 | $10B | $2B | $0B | $0B | $1B | $1B |
| FY+3 | $10B | $2B | $0B | $0B | $2B | $1B |
| FY+4 | $11B | $2B | $0B | $0B | $2B | $1B |
| FY+5 | $11B | $2B | $0B | $0B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 18x | $19B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $6B + PV(terminal) $19B = EV $25B; + net cash → equity $23B ÷ diluted shares 0.24B = $98/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $88/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 16% vs WACC 9% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| PH | 6.38x | 29.07x | 5% | 22% |
| ITW | 5.31x | 23.31x | 5% | 26% |
| GWW | 3.563x | 30.03x | 5% | 17% |
| IR | 4.567x | 23.58x | 5% | 17% |
| Median | 4.9384999999999994x | 26.325x | — | — |
Peer-median fwd P/E → $145; EV/Rev → $182.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $98 | 41% | $40 |
| Scenario PWEV | $114 | 29% | $34 |
| Monte Carlo median | $103 | 18% | $18 |
| Peer P/E | $145 | 12% | $17 |
| Triangulated | — | 100% | $109 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 12.6x | 15.3x | 18.0x | 20.7x | 23.4x |
|---|---|---|---|---|---|
| 7% | $81 | $94 | $107 | $120 | $133 |
| 8% | $77 | $90 | $102 | $115 | $127 |
| 9% | $74 | $86 | $98 | $110 | $122 |
| 10% | $71 | $82 | $94 | $105 | $116 |
| 11% | $68 | $79 | $90 | $101 | $111 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $70 | $77 | $85 | $92 | $100 |
| -1.5pp | $75 | $83 | $91 | $99 | $107 |
| +0.0pp | $81 | $89 | $98 | $106 | $115 |
| +1.5pp | $87 | $96 | $105 | $114 | $123 |
| +3.0pp | $93 | $103 | $112 | $122 | $131 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $81 | $115 | $34 |
| Revenue CAGR ±3pp | $85 | $112 | $27 |
| Terminal × ±15% | $86 | $110 | $24 |
| WACC ±1pp | $94 | $102 | $9 |
| Capex intensity ±15% | $94 | $102 | $8 |
Company lever — SoP/share vs Diversified Industrial Machinery multiple (AI re-rating) (base 21x)
| Multiple | 14.7x | 17.8x | 21.0x | 24.1x | 27.3x |
|---|---|---|---|---|---|
| SoP/share | $554 | $673 | $794 | $912 | $1,034 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $151 (+25% vs spot · street) |
| House target | $116 (-23.2% vs street) |
| Sell-side coverage | 23 analysts (SB 5 / B 10 / H 8 / S 0 / SS 0; net score 0.43) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $0.6B — modestly levered |
| Net debt / EBITDA | 0.31x |
| Interest coverage (EBIT / interest) | 41.7x |
| Current ratio | 1.62x |
| Lease obligations | $0.1B |
| Cash & ST investments | $1.5B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $0.9B |
| Buybacks / dividends | $0.0B / $0.4B |
| Total shareholder yield | 1.4% |
| Payout as % of FCF | 44.6% |
| Reinvestment (capex / OCF) | 26.7% |
| SBC as % of FCF | 5.8% |
| Allocation stance | balanced |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 10.0% |
| FCF conversion (FCF / net income) | 95.8% |
| FCF yield | 3.1% |
| Capex intensity (capex / revenue) | 3.6% |
| FCF − SBC (diagnostic) | $0.9B |
| Capex split (maint / growth) | 55% / 45% — Moderately capital-light industrial; maintenance sustains manufacturing/service network, growth funds capacity, digital/analytics and Evoqua-platform integration. |
Accounting quality: SBC 0.6% of revenue; cash conversion (OCF/NI) 131% — cash-backed.
Catalyst Calendar
- 2026-02-03 (~-155d) — Q4/FY2025 results, FY2026 organic guide and Evoqua-synergy update (authored)
- 2026-05-14 (~-55d) — Investor day — long-term margin-bridge and capital-allocation framework (authored)
- 2026-07-28 (~20d) — Quarterly earnings — est. EPS $1.34 (AV EARNINGS_CALENDAR)
- 2026-10-28 (~112d) — Measurement & Control Solutions (smart-metering) backlog / AMI award milestone (authored)
Forecast Track Record
- EPS surprise: beat 87.5% of the last 8 quarters; average surprise +5.3%.
Competitive Moat
Narrow moat. XYL's moat is an installed base of water-infrastructure equipment, specification/regulatory design-in, and aftermarket/service attach — real but not wide given competitive pump/analytics markets. Falsifiable: at ~21x the market pays a modest premium; if organic growth reverts to low-single-digit and the 17.5% operating margin fails to expand post-Evoqua synergies for two years, the terminal multiple should compress toward the diversified-industrial ~16-17x.
Moat sources:
- Large installed base of pumps/treatment equipment driving recurring aftermarket and service revenue
- Specification and regulatory design-in with municipal/utility water customers (long replacement cycles)
- Water-quality analytics and Evoqua treatment platform broadening the solutions moat
- Faces credible competition (Grundfos, OEMs, analytics entrants) — a solutions moat, not a monopoly
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Municipal/utility water-infrastructure funding (IIJA) timing and PFAS-treatment mandates | medium (~45%) | medium - regulation is a demand tailwind but funding/timing swings the growth path, ~4-6% of FV | 12-24m |
| Environmental/emissions and product-standards compliance across geographies | low (~20%) | low - incremental compliance cost, <3% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Portfolio / End-Market Disruption | Competitive/portfolio disruption or a permanent water-capex spend shift erodes the installed-base advantage. | Margin and multiple de-rate together toward the industrial cohort. |
| Industrial-PMI Recession | Short-cycle industrial demand contracts with a PMI-led downturn; utility capex defers. | De-leverage on the fixed cost base compresses the 17.5% operating margin. |
| Base — Organic Growth + Margin | Short-cycle demand normalises; steady municipal/utility water demand supports mid-single-digit organic. | P/E and gross margin dominate variance and cut both ways at ~21x. |
| Growth — Productivity / Reshoring / Automation | Reshoring, water-scarcity investment and automation lift organic growth and Evoqua synergies land. | Synergy realisation and margin bridge under-deliver versus plan. |
| Bull — Re-Rate | Falling rates and a secular-water-theme bid expand the multiple above mid-cycle. | The re-rate is multiple-led and reverses if organic growth disappoints. |
What the Market Is Pricing In
The house DCF sits 19% below spot, so the market is pricing in more than the house case — roughly 2.1pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | — | 9.5 | High |
| EPS | — | 5.5 | Medium |
| Target price | 150.9 | 115.9 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| PH | 29.07× | 5% | 22% | segment | 50% |
| ITW | 23.31× | 5% | 26% | direct | 100% |
| GWW | 30.03× | 5% | 17% | segment | 50% |
| IR | 23.58× | 5% | 17% | direct | 100% |
Quality-weighted forward P/E: 25.5× (simple median 26.325×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $105–$153, centre $127 (+5% vs spot); spot sits at the 33th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $109 (-10% vs spot · triangulated FV) |
| Downside to bear case (Structural — Portfolio / End-Market Disruption) | $54 (-55% vs spot · bear scenario) |
| Reward/risk ratio | 0.2× |
| Margin of safety (FV vs spot) | -11% |
| P(price > spot) — Monte Carlo | 37% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $196.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 9.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 18× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (34.0); Revenue CAGR ±3pp (27.0); Terminal × ±15% (24.0); WACC ±1pp (9.0); Capex intensity ±15% (8.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $9.1B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $9.5B | company guidance | Company guidance | Medium | Forecast, SoP |
| Diluted shares | 0.24B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $0.584B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 9.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 18× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 9%, terminal multiple 18×, FY+5 revenue $11B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic revenue growth (y/y) < 0.01 (2 consecutive prints → Industrial-PMI Recession / Inventory Reset). Base case assumes ~5% organic growth. Two prints near flat would confirm the short-cycle destock has arrived and pull the mid-cycle path toward the PMI-recession case.
- Adjusted operating margin < 0.165 (2 consecutive prints → Industrial-PMI Recession / Inventory Reset). Base op margin is 17.5%. A drift to the midpoint of base and the PMI-recession margin signals negative operating leverage rather than transient mix, weakening the margin leg of the thesis.
- Book-to-bill / orders growth < 1.0 (2 consecutive prints → Industrial-PMI Recession / Inventory Reset). Orders below shipments for two quarters is the leading tell that short-cycle demand is rolling over ahead of the revenue line.
- Forward-year revenue guidance (FY midpoint, $B) < 9.3 (single event → Industrial-PMI Recession / Inventory Reset). FY guidance below the current ~$9.5B line and toward $9.3B would move consensus toward the recession path and remove the mid-cycle premium embedded in the multiple.
- Free cash flow conversion (FCF / net income) < 0.9 (2 consecutive prints → Mid-Cycle — Volumes + Pricing). Capital discipline underpins the returns case. Conversion sliding below ~0.9 for two prints would indicate working-capital or capex leakage that undercuts the shareholder-return support for the current valuation.
Fact / Inference / Speculation
- FACT: Spot $121; 52-week range $105–$153; engine rating HOLD; base-case target $116 (-4%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $109 (-10% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $109 (-10% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.